These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9337537

  • 41. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
    Birkenfeld S, Noiman G, Krispin M, Schwartz S, Zakut H.
    Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
    [Abstract] [Full Text] [Related]

  • 42. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM, Sauer-Eppel H, Bruzdziak TH.
    Anticancer Res; 2007 Apr; 27(4A):1911-5. PubMed ID: 17649794
    [Abstract] [Full Text] [Related]

  • 43. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 44. Lung tumours immunoreactive for parathyroid hormone related peptide: analysis of serum calcium levels and tumour type.
    Davidson LA, Black M, Carey FA, Logue F, McNicol AM.
    J Pathol; 1996 Apr; 178(4):398-401. PubMed ID: 8691317
    [Abstract] [Full Text] [Related]

  • 45. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D, Ciocci L, Cicerone E, Rossi C, Tiboni F, Ferrauti P, Gallo A, Baroni CD.
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [Abstract] [Full Text] [Related]

  • 46. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.
    Chantapet P, Riantawan P, Lebnak P, Getngern P.
    J Med Assoc Thai; 2000 Apr; 83(4):383-91. PubMed ID: 10808698
    [Abstract] [Full Text] [Related]

  • 47. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M, Kocher T, Adamina M, Guller U, Dalquen P, Haas P, Mirlacher M, Gambazzi F, Harder F, Heberer M, Sauter G, Spagnoli GC.
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [Abstract] [Full Text] [Related]

  • 48. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K.
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [Abstract] [Full Text] [Related]

  • 49. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J, Presek P, Braun A, Bauer P, Konietzko N, Wiesner B, Woitowitz HJ.
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [Abstract] [Full Text] [Related]

  • 50. Clinical use of gynaecologic tumour markers.
    Halila H, Alfthan H, Stenman UH.
    Ann Chir Gynaecol; 1989 Aug; 78(1):65-70. PubMed ID: 2547331
    [Abstract] [Full Text] [Related]

  • 51. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K.
    Hepatogastroenterology; 2008 Aug; 55(82-83):388-93. PubMed ID: 18613372
    [Abstract] [Full Text] [Related]

  • 52. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
    Wu GP, Zhang SS, Fang CQ, Liu SL, Wang EH.
    Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
    [Abstract] [Full Text] [Related]

  • 53. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [Abstract] [Full Text] [Related]

  • 54. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
    Zheng H, Tsuneyama K, Takahashi H, Miwa S, Nomoto K, Saito H, Masuda S, Takano Y.
    Anticancer Res; 2007 Sep; 27(1B):575-81. PubMed ID: 17348444
    [Abstract] [Full Text] [Related]

  • 55. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
    Arora B, Chhabra A, Yadav MS, Arora DR.
    Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
    [Abstract] [Full Text] [Related]

  • 56. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [Abstract] [Full Text] [Related]

  • 57. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S, Freund M, Rogatsch H, Krabichler S, Berger P.
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [Abstract] [Full Text] [Related]

  • 58. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F.
    Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189
    [Abstract] [Full Text] [Related]

  • 59. [Interleukin 3 (IL-3) in diagnosis and monitoring of non-small-cell lung cancer].
    Mroczko B, Szmitkowski M, Czygier M.
    Przegl Lek; 1999 Feb 01; 56(12):763-6. PubMed ID: 10789186
    [Abstract] [Full Text] [Related]

  • 60. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.
    Leinonen T, Pirinen R, Böhm J, Johansson R, Ropponen K, Kosma VM.
    Lung Cancer; 2006 Mar 01; 51(3):313-21. PubMed ID: 16423426
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.